Browers Blaine

CFO Browers Blaine sold 20,435 shares of CDRE at $43.79 (now $41.74); holding declined 24.5% to 63,142 shares.

Browers Blaine, CFO of Cadre Holdings, sold 20,435 shares at $43.79 on 2025-12-12, reducing his post-transaction holdings to 63,142 shares—a 24.5% reduction from his pre-transaction 83,577 shares. The sale occurred near the 52-week high of $45.11 and significantly above the current price of $41.74. His prior sell at this ticker on 2024-11-12 was followed by a 90-day return of +6.6%, indicating the stock rose after that earlier sale rather than declining; across his full cross-ticker track record, his prior sells show an average 90-day return of +6.6%, with a well-timed rate of 0.00%, meaning none were followed by stock declines. The company's fundamentals show revenue of $155,869,000.00 and net income of $10,941,000.00 in the latest quarter, with 17.6% annual revenue growth, though the P/E ratio of 37.27 reflects a premium valuation.

CFO Blaine Browers sells 30,000 CDRE shares at $34.06; post-trade holdings reduced -27.8% to 77,876 shares

CFO Blaine Browers sold 30,000 shares (30.0K shares) at $34.06 on 2024-11-12, reducing his stake from 107,876 shares to 77,876 shares, a -27.8% reduction in his holdings. The sale occurred at a price notably above the current $33.33 level and within the 52-week range of $29.90–$40.22, but the stock has declined 17.1% from its 52-week high and 13.5% over the past 30 days. The company shows modest annual revenue growth of +5.4% on a $109.4M quarterly revenue base with a $3.7M net income quarter, supported by a $1.4B market cap, though the elevated P/E of 41.15 reflects growth expectations the recent price action does not support. The substantial proportional reduction in the CFO's personal holding warrants attention to whether this reflects portfolio rebalancing or changed circumstances, particularly given recent downward price momentum.